Current concepts in neuro-oncology

Advances in Neurology
|January 1, 1976
PubMed

Insights

Neuro-oncology research is advancing with new agents and tools for studying brain tumors. This chapter explores cancer theories, immunology, and epigenetics in neural neoplasms.

Area of Science:

  • Neuroscience
  • Oncology
  • Molecular Biology

Background:

  • Neuro-oncology is experiencing a resurgence driven by new neuro-oncogenic agents and experimental tools.
  • Research focuses on brain tumor study using radiotherapy, chemotherapy, and immunology.
  • Current interest areas include cancer theories, immunology, and epigenetics in neural neoplasms.

Purpose of the Study:

  • To discuss naturally occurring and experimentally induced nervous system tumors.
  • To relate these tumors to key areas of oncology: somatic mutation, viral theories, immunological surveillance, and epigenetic mechanisms.
  • To highlight the suitability of neural neoplasms for studying epigenetic phenomena.

Main Methods:

  • Review of observations on naturally occurring and experimentally induced nervous system tumors.
  • Discussion of established and emerging theories in cancer research (somatic mutation, viral, immunological, epigenetic).
  • Utilizing new tools for experimental brain tumor study (radiotherapeutic, chemotherapeutic, immunological).

Main Results:

  • Neural neoplasms are ideal models for studying epigenetic phenomena due to distinct markers.
  • Allows clear definition of divergent differentiation stages in neurocytogenesis.
  • Provides insights into altered gene expression patterns in neoplastic systems.

Conclusions:

  • Advances in neuro-oncology are facilitated by new agents and experimental methodologies.
  • Understanding epigenetic mechanisms in neural neoplasms is crucial for cancer research.
  • Neural neoplasms offer unique advantages for dissecting complex biological processes in cancer development.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...